Evidence map›Paper›PMID 34939006›Full record

ArticleKidney medicine

Health-Related Quality of Life in Older Kidney Transplant Recipients: A National Cohort Study of Short- and Longer-Term Outcomes.

Vasiliki Tsarpali, Karsten Midtvedt, Kjersti Lønning, Tomm Bernklev, Nanna von der Lippe, Anna Varberg Reisæter, Cathrine Brunborg, Kristian Heldal

Open access · goldAbstract read
In one paragraph

Article in Kidney medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Health-related quality of life in kidney transplant recipients: association with graft function and comparison to patients on dialysis.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Kidney Transplantation Improves Health-Related Quality of Life in Older Recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vasiliki TsarpaliClinic of Internal Medicine, Telemark Hospital Trust, Skien, Norway.
Karsten MidtvedtDepartment of Transplantation Medicine, Section of Nephrology, Oslo University Hospital, Oslo, Norway.
Kjersti LønningDepartment of Transplantation Medicine, Section of Nephrology, Oslo University Hospital, Oslo, Norway.
Tomm BernklevFaculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Nanna von der LippeFaculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Anna Varberg ReisæterDepartment of Transplantation Medicine, Section of Nephrology, Oslo University Hospital, Oslo, Norway.
Cathrine BrunborgOslo Center for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.
Kristian HeldalClinic of Internal Medicine, Telemark Hospital Trust, Skien, Norway.
Oslo University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RATIONALE &

objectiveAssessing the optimal therapy for older patients (aged ≥65 years) with end-stage kidney disease requires knowledge of longevity and health-related quality of life (HRQoL) outcomes. Kidney transplantation prolongs survival but its long-term impact on HRQoL in older recipients is not well defined. We aimed to prospectively evaluate HRQoL changes from enlisting until 3 years posttransplantation and examine pretransplantation predictors of posttransplantation outcomes. STUDY

designProspective cohort study. SETTING &

participantsPatients 65 years and older enlisted at the Norwegian National Transplant Center between January 2013 and November 2016. PREDICTORS: Kidney transplantation, dialysis vintage, and pretransplantation comorbidity assessed using the Liu Comorbidity Index. OUTCOMES: HRQoL, assessed using the Kidney Disease Quality of Life Short Form, version 1.3. ANALYTICAL APPROACH: HRQoL scores obtained at 3 years posttransplantation were compared with those obtained pretransplantation and after 1 year using a paired-sample

resultsAmong 289 patients included, 220 (mean age, 71.5 years) had undergone transplantation and 136 had completed the 3-year HRQoL follow-up by October 2020. Posttransplant HRQoL, both generic and kidney specific, substantially improved and the benefit persisted for 3 years. For wait-listed candidates remaining on dialysis, HRQoL gradually deteriorated, and recipients who died within 3 years posttransplantation experienced no improvement during the first year. Moderately elevated pretransplantation comorbidity scores and prolonged dialysis vintage independently predicted poor HRQoL outcomes posttransplantation. Recipients receiving dialysis for 1 year or longer with pretransplantation comorbidity scores ≥ 7 experienced a marked and sustained physical deterioration after transplantation. LIMITATIONS: Homogenous and highly selected population.

conclusionsTransplantation is associated with a sustained HRQoL improvement and should be the preferred treatment for selected older patients. The value of a pretransplant comorbidity score to predict posttransplantation outcomes warrants further evaluation and may improve the selection process.

Indexed as

comorbidity scoredialysiselderlyHealth-related quality of lifeHRQoLkidney transplantationoutcomespredictors

Identifiers

PMID34939006
PMCPMC8664696
OpenAlexW3184736296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.